Search
for
Sort by
Research 241–270 of 1000+
- Gender-Affirming Hormone Therapy for Transgender Men
- Androgen treatment of postmenopausal women
- Androgen antagonists in androgen target tissues
- Inducing hair follicle neogenesis with secreted proteins enriched in embryonic skin
- Prescribing testosterone and DHEA: The role of androgens in women
- Exploring pericyte and cardiac stem cell secretome unveils new tactics for drug discovery
- Testosterone therapy in men: Clinical and pharmacological perspectives
- Recurrence of Pemphigus Vulgaris Associated With Interleukin 2 Therapy
- Pre-clinical non-viral vectors exploited for<i>in vivo</i>CRISPR/Cas9 gene editing: an overview
- Male hormonal contraception: looking back and moving forward
- Contraception and the dermatologist
- Cross-sex hormone therapy for gender dysphoria
- Teriflunomide in multiple sclerosis: an update
- What is the Rationale for Androgen Therapy for Women?
- Pro-Insulin-Like Growth Factor-II Ameliorates Age-Related Inefficient Regenerative Response by Orchestrating Self-Reinforcement Mechanism of Muscle Regeneration
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Evaluation and Treatment of Gender Dysphoria to Prepare for Gender Confirmation Surgery
- Lessons Learned from the First Decade of Laser-Assisted Drug Delivery
- Teriflunomide: a novel oral treatment for relapsing multiple sclerosis
- What′s new in cicatricial alopecia?
- Targeting host cell proteases as a potential treatment strategy to limit the spread of SARS‐CoV‐2 in the respiratory tract
- Protective cardiovascular and renal actions of vitamin D and estrogen
- Design of an artificial skin. IV. Use of island graft to isolate organ regeneration from scar synthesis and other processes leading to skin wound closure
- Male fertility and skin diseases
- A Critical Review on Obstetric Follow-up of Women Affected by Systemic Lupus Erythematosus
- The Safety of Testosterone Therapy in Women
- CUTANEOUS T-CELL LYMPHOMA
- Immunomodulators in the treatment of cutaneous lymphoma
- Transfollicular drug delivery: current perspectives
- Recommendations of endocrine treatment for patients with gender dysphoria